发明名称 |
Implantable tizanidine compositions and methods of treatment thereof |
摘要 |
A method of treating the symptoms of spasticity comprises implanting a reservoir-based drug delivery composition into a subject to systemically deliver a therapeutically effective amount of tizanidine to the subject for a long period of time (e.g., one month or one year). The drug delivery composition may include a rate-controlling excipient (e.g., an elastomeric polymer) defining a reservoir containing at least one discrete solid dosage form (e.g., one or more pellets), which includes tizanidine free base and optionally, a sorption enhancer. |
申请公布号 |
US9011910(B2) |
申请公布日期 |
2015.04.21 |
申请号 |
US201313899704 |
申请日期 |
2013.05.22 |
申请人 |
Braeburn Pharmaceuticals BVBA SPRL |
发明人 |
Schwarz Alexander |
分类号 |
A61K9/00;A61K31/433;A61K45/06 |
主分类号 |
A61K9/00 |
代理机构 |
RatnerPrestia |
代理人 |
RatnerPrestia |
主权项 |
1. A method of treating one or more symptoms of spasticity comprising:
implanting a reservoir-based drug delivery composition into a subject to systemically deliver a therapeutically effective amount of tizanidine to the subject for a period of time of at least one month, wherein the drug delivery composition comprises at least one discrete solid dosage form comprising tizanidine free base surrounded by a drug elution rate-controlling excipient comprising at least one elastomeric polymer defining a reservoir, wherein the elastomeric polymer comprises a polyether polyurethane. |
地址 |
Brussels BE |